CD274 and melanoma: ExoPD-L1 from sulfasalazine (SAS)-treated melanoma cells promotes M2 macrophage polarization by upregulating PD-L1 expression, contributing to immune evasion and resistance to PD-1/PD-L1 blockade [48].